PULMOCIDE Trademark

Trademark Overview


On Thursday, September 1, 2022, a trademark application was filed for PULMOCIDE with the United States Patent and Trademark Office. The USPTO has given the PULMOCIDE trademark a serial number of 79351406. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by Pulmocide Limited. The PULMOCIDE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, oncologic diseases, dermatologic diseases, infectious-related diseases, respiratory diseases; medical preparations for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, oncologic diseases, dermatologic diseases, infectious-related diseases, respiratory diseases; fungicide; antifungal treatment preparations; preparations for treatment of lung infection; medicines for the treatment of respiratory disorders; inhalable antifungal treatment preparations

Medical and pharmacological research services; pharmaceutical research and development; pharmaceutical product development and testing
pulmocide

General Information


Serial Number79351406
Word MarkPULMOCIDE
Filing DateThursday, September 1, 2022
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7307307
Registration DateTuesday, February 20, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, oncologic diseases, dermatologic diseases, infectious-related diseases, respiratory diseases; medical preparations for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, oncologic diseases, dermatologic diseases, infectious-related diseases, respiratory diseases; fungicide; antifungal treatment preparations; preparations for treatment of lung infection; medicines for the treatment of respiratory disorders; inhalable antifungal treatment preparations
Goods and ServicesMedical and pharmacological research services; pharmaceutical research and development; pharmaceutical product development and testing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePulmocide Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NamePulmocide Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NamePulmocide Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Sunday, December 3, 2023NOTIFICATION PROCESSED BY IB
Wednesday, November 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 15, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 27, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, October 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 15, 2023REFUSAL PROCESSED BY IB
Tuesday, July 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 25, 2023REFUSAL PROCESSED BY MPU
Wednesday, June 21, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 20, 2023NON-FINAL ACTION WRITTEN
Monday, June 19, 2023ASSIGNED TO EXAMINER
Tuesday, October 4, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 29, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB